Early cardiac events after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. subanalysis exploring cardiac toxicity conducted on behalf of GETH-TC

While the incidence of ECEs following haplo-HCT with PTCY was relatively low, their occurrence significantly worsened transplant outcomes. These findings underscore the importance of cardiovascular risk assessment and structured cardiac monitoring to mitigate complications in haplo-HCT recipients.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-05-01
DOI
https://doi.org/10.3389/fimmu.2025.1571678
Citations
4
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
7.08
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early cardiac events after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. subanalysis exploring cardiac toxicity conducted on behalf of GETH-TC

Inmaculada Heras Fernando, Adolfo Jesús Sáez Marín, Lucía García, Enric Cascos et al.
4 citations
Frontiers in Immunology
Hematopoietic Stem Cell Transplantation
7.08
article

Early cardiac events after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. subanalysis exploring cardiac toxicity conducted on behalf of GETH-TC

Inmaculada Heras Fernando, Adolfo Jesús Sáez Marín, Lucía García, Enric Cascos, Sara Villar, Juan José Domínguez-García, María Queralt Salas, Mónica Baile-González, Tamara Torrado, Guillermo Ortí, Miguel Fernández de Sanmamed Girón, Sara Fernández‐Luis, Albert Esquirol, Carmen Calvo, Leslie González Pinedo, José Luis López Lorenzo, Ana Pilar González, Filipe R. Pinto, Marta Luque, Estefanía Pérez‐López, Felipe Peña-Muñóz, Silvia Filaferro, Manuel Jurado Chacón, Pascual Basalobre, Itziar Oiartzabal Ormtegi, María Jesús Pascual Cascón, Carlos Martín Rodríguez, Alberto López-García
article en
4 citations

Abstract

While the incidence of ECEs following haplo-HCT with PTCY was relatively low, their occurrence significantly worsened transplant outcomes. These findings underscore the importance of cardiovascular risk assessment and structured cardiac monitoring to mitigate complications in haplo-HCT recipients.

Frontiers in ImmunologyVol. 16
Hospital de Sant Pau (ES), Hospital General Universitario Morales Meseguer (ES), Hospital Universitario de Gran Canaria Doctor Negrín (ES), Hospital Universitario 12 De Octubre (ES), Institut Català d'Oncologia (ES), Hospital Regional Universitario de Málaga (ES), Instituto de Investigación Marqués de Valdecilla (ES), Hospital Clínic de Barcelona (ES), Hospital Universitario Virgen de las Nieves (ES), Hospital Universitario Reina Sofía (ES), Vall d'Hebron Hospital Universitari (ES), Hospital Universitario Fundación Jiménez Díaz (ES), Hospital Universitario Central de Asturias (ES), Instituto de Investigación Biomédica de Salamanca (ES), Clinica Universidad de Navarra (ES), Donostiako Unibertsitate Ospitalea (ES), Complexo Hospitalario Universitario A Coruña (ES), Duran i Reynals Hospital (ES), Hospital Universitario Son Espases (ES)
Openalex Percentile: Top 3%
Hematopoietic Stem Cell Transplantation
7.08
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.